Tushar Date, Ph.D.

Business Analyst - Strategy at LSC - LifeSciences Consultants
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Hyderabad, Telangana, India, IN
Languages
  • English -
  • Hindi -
  • Marathi -
  • Sanskrit -

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Credentials

  • Pharmaceutical Business Intelligence by DrugPatentWatch
    Udemy
    Feb, 2022
    - Nov, 2024
  • AASLD 2021 Conference
    American Association for the Study of Liver Diseases (AASLD)
    Nov, 2021
    - Nov, 2024
  • ESMO-2021 Conference Coverage
    ESMO - European Society for Medical Oncology
    Sep, 2021
    - Nov, 2024
  • General Course On Intellectual Property
    World Intellectual Property Organization
    Feb, 2015
    - Nov, 2024

Experience

    • Business Consulting and Services
    • 1 - 100 Employee
    • Business Analyst - Strategy
      • Oct 2022 - Present

      • Go-to-market strategy • Alliance planning and partnership opportunity mapping • Clinical development, asset prioritization strategy and opportunity assessment (Oncology product) • Reimbursement landscape, market access challenges and strategies to overcome them • Primary research (KOL & Payers) • BD proposal development • Gene therapy launch strategies and pre-launch planning • Country-level gene therapy administration capacity assessment • Involved in recruitment… Show more • Go-to-market strategy • Alliance planning and partnership opportunity mapping • Clinical development, asset prioritization strategy and opportunity assessment (Oncology product) • Reimbursement landscape, market access challenges and strategies to overcome them • Primary research (KOL & Payers) • BD proposal development • Gene therapy launch strategies and pre-launch planning • Country-level gene therapy administration capacity assessment • Involved in recruitment, training of newly hired resources, expansion of the India office and scaling it to 10x employee size Show less • Go-to-market strategy • Alliance planning and partnership opportunity mapping • Clinical development, asset prioritization strategy and opportunity assessment (Oncology product) • Reimbursement landscape, market access challenges and strategies to overcome them • Primary research (KOL & Payers) • BD proposal development • Gene therapy launch strategies and pre-launch planning • Country-level gene therapy administration capacity assessment • Involved in recruitment… Show more • Go-to-market strategy • Alliance planning and partnership opportunity mapping • Clinical development, asset prioritization strategy and opportunity assessment (Oncology product) • Reimbursement landscape, market access challenges and strategies to overcome them • Primary research (KOL & Payers) • BD proposal development • Gene therapy launch strategies and pre-launch planning • Country-level gene therapy administration capacity assessment • Involved in recruitment, training of newly hired resources, expansion of the India office and scaling it to 10x employee size Show less

    • United States
    • Business Consulting and Services
    • 1 - 100 Employee
    • Senior Business Analyst
      • Aug 2021 - Oct 2022

      • Strategic CI in oncology clinical research • Pharmaceutical competitive intelligence • Understanding major pharma research updates and correlating them with future business impact • Insights generation • Conference coverage • Digital marketing strategy • KOL identification & engagement • Competitive landscaping • News alerts & business insights tracking • Investor release & earning call monitoring • Strategic CI in oncology clinical research • Pharmaceutical competitive intelligence • Understanding major pharma research updates and correlating them with future business impact • Insights generation • Conference coverage • Digital marketing strategy • KOL identification & engagement • Competitive landscaping • News alerts & business insights tracking • Investor release & earning call monitoring

    • Ph.D. Researcher
      • Aug 2017 - Oct 2021

      • 20+ peer-reviewed publications in international journals and 15+ conference presentations • Designing nanocarrier-based drug delivery strategies for drugs/genes to improve the treatment of cancer, diabetes, psoriasis, and microbial infections • Design, development, and execution of structured scientific experiments • Scientific literature search and hypothesis building • Writing & presenting scientific findings in research papers, scientific reviews, book chapters & international… Show more • 20+ peer-reviewed publications in international journals and 15+ conference presentations • Designing nanocarrier-based drug delivery strategies for drugs/genes to improve the treatment of cancer, diabetes, psoriasis, and microbial infections • Design, development, and execution of structured scientific experiments • Scientific literature search and hypothesis building • Writing & presenting scientific findings in research papers, scientific reviews, book chapters & international conferences • Writing scientific grants and initiating collaborative research projects • Mentoring post-graduate students to resolve research challenges • Worked on multiple academia-industry collaborative R&D projects • Lab inventory management & ensuring steady research resource supply Show less • 20+ peer-reviewed publications in international journals and 15+ conference presentations • Designing nanocarrier-based drug delivery strategies for drugs/genes to improve the treatment of cancer, diabetes, psoriasis, and microbial infections • Design, development, and execution of structured scientific experiments • Scientific literature search and hypothesis building • Writing & presenting scientific findings in research papers, scientific reviews, book chapters & international… Show more • 20+ peer-reviewed publications in international journals and 15+ conference presentations • Designing nanocarrier-based drug delivery strategies for drugs/genes to improve the treatment of cancer, diabetes, psoriasis, and microbial infections • Design, development, and execution of structured scientific experiments • Scientific literature search and hypothesis building • Writing & presenting scientific findings in research papers, scientific reviews, book chapters & international conferences • Writing scientific grants and initiating collaborative research projects • Mentoring post-graduate students to resolve research challenges • Worked on multiple academia-industry collaborative R&D projects • Lab inventory management & ensuring steady research resource supply Show less

    • India
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Formulation Scientist R&D (Injectables)
      • Aug 2016 - Jul 2017

      • Involved in formulation research of nanocrystal-based sustained release injectable suspensions, proteins, and peptide injectables, and modified cyclodextrin-based products • Design and execution of formulation trial batches and their stability analysis • Regulatory landscape, patents, and literature search of products • License application and product selection process • Involved in formulation research of nanocrystal-based sustained release injectable suspensions, proteins, and peptide injectables, and modified cyclodextrin-based products • Design and execution of formulation trial batches and their stability analysis • Regulatory landscape, patents, and literature search of products • License application and product selection process

    • United Kingdom
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Trainee
      • Nov 2012 - Dec 2012

Education

  • National Institute of Pharmaceutical Education and Research (NIPER) ,SAS NAGAR , Mohali
    Doctor of Philosophy - PhD, Pharmaceutics and Drug Design
    2017 - 2021
  • Birla Institute of Technology and Science, Pilani
    M.Pharm (Pharmaceutics), Pharmaceutics and Drug Design
    2014 - 2016
  • NDMVP'S College of Pharmacy, Nashik
    Bachelor of Pharmacy (B.Pharm.), Pharmaceutical Sciences
    2010 - 2014

Community

You need to have a working account to view this content. Click here to join now